Production (Stage)
The Chemours Company
CC
$10.30
-$0.55-5.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.74% | -4.66% | -3.18% | -7.86% | -10.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.74% | -4.66% | -3.18% | -7.86% | -10.08% |
| Cost of Revenue | 0.38% | -2.64% | -1.45% | -4.12% | -7.60% |
| Gross Profit | -9.90% | -12.02% | -9.74% | -20.82% | -18.48% |
| SG&A Expenses | -1.69% | 2.94% | -14.52% | -10.90% | -14.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.11% | -1.98% | -2.95% | -4.93% | -8.28% |
| Operating Income | -20.92% | -28.27% | -5.57% | -32.44% | -25.25% |
| Income Before Tax | 114.56% | 141.46% | 116.77% | 420.00% | -166.09% |
| Income Tax Expenses | 132.26% | 151.85% | -- | -141.38% | -164.14% |
| Earnings from Continuing Operations | 109.51% | 137.87% | 125.63% | 236.36% | -166.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.45% | 137.55% | 125.00% | 234.09% | -167.08% |
| EBIT | -20.92% | -28.27% | -5.57% | -32.44% | -25.25% |
| EBITDA | -12.32% | -19.55% | -4.71% | -23.10% | -17.42% |
| EPS Basic | 109.46% | 137.57% | 125.04% | 221.48% | -169.66% |
| Normalized Basic EPS | -41.71% | -48.43% | -25.68% | -58.77% | -46.89% |
| EPS Diluted | 108.59% | 135.98% | 123.95% | 211.84% | -171.50% |
| Normalized Diluted EPS | -41.60% | -48.22% | -25.20% | -58.51% | -46.08% |
| Average Basic Shares Outstanding | 0.54% | 0.40% | 0.05% | -1.25% | -2.45% |
| Average Diluted Shares Outstanding | 0.23% | 0.06% | -0.29% | -1.46% | -3.31% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 11.51% | 3.65% | 5.00% | 1.73% | -2.47% |